14,15-epoxy-5,8,11-eicosatrienoic acid has been researched along with Lung Diseases in 1 studies
14,15-epoxy-5,8,11-eicosatrienoic acid: RN given refers to cpd without isomeric designation
Lung Diseases: Pathological processes involving any part of the LUNG.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Flitter, BA | 1 |
| Hvorecny, KL | 1 |
| Ono, E | 1 |
| Eddens, T | 1 |
| Yang, J | 1 |
| Kwak, DH | 1 |
| Bahl, CD | 1 |
| Hampton, TH | 1 |
| Morisseau, C | 1 |
| Hammock, BD | 1 |
| Liu, X | 1 |
| Lee, JS | 1 |
| Kolls, JK | 1 |
| Levy, BD | 1 |
| Madden, DR | 1 |
| Bomberger, JM | 1 |
1 other study available for 14,15-epoxy-5,8,11-eicosatrienoic acid and Lung Diseases
| Article | Year |
|---|---|
Pseudomonas aeruginosa sabotages the generation of host proresolving lipid mediators.
Topics: 8,11,14-Eicosatrienoic Acid; Bacterial Proteins; Bronchoalveolar Lavage Fluid; Cell Line; Crystallog | 2017 |